The Pharmaceutical Chemistry Branch organized a panel discussion entitled "Preparing and diagnosing new compounds and evaluating them as an effective treatment against disease
Alzheimer's, where Dr. Sita Azad Agord explained that the preparation of lycanate is effective and a mechanical study of acetile inhibitors Colleen Estres and Butiel Choline Estres and study the efficacy of lycanate with different metals and their ability to cross the brain barrier It has the potential to link with iron, copper and zinc metals to reduce these metals in Alzheimer's patients as well as explained The symptoms of this disease are anxiety, stress, hallucinations, memory loss and abnormal behaviors.
